Navigation Links
Sciton Introduces ProLipo PLUS(TM), the Most Robust Laser-Assisted Lipolysis System Available
Date:12/1/2008

ith local anesthesia," said Robert Ruck, Vice President of World Wide Marketing at Sciton. "Furthermore, our system is a safe investment because of its modular, fully upgradeable platform and use of open-source fibers."

The following array of body treatment areas can effectively be contoured and tightened using ProLipo PLUS: chin, jowls, neck, arms, back, abdomen, flanks, hips, waist, thighs, buttocks, knees and male chest.

Visit http://www.ProLipoPlus.com for more about Sciton's new ProLipo PLUS.


'/>"/>
SOURCE Sciton
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Sciton Introduces ProFractional-XC(TM), High-Speed, Dual-Mode Fractional Laser
2. HOYA ConBio(TM) Introduces VersaWave(R) Specialty Laser
3. Miami's Soluna MD Introduces New Cosmetic Surgery Facelift Technique With Permalift
4. PC Brands Introduces Great Tasting Shelf-Stable Nutrition Bar With Probiotics
5. NMB Introduces Custom Built Bearing Assemblies
6. SCM Microsystems Introduces New Mobile Terminal for the German Electronic Health Card
7. Anthem Blue Cross and Blue Shield Introduces International Medical Tourism Pilot Program
8. GEMS Introduces Ultrasonic Continuous Liquid Level Sensor with Multipoint Switch Capability
9. Coromega Unveils New Healthy Heart and CoQ10 Supplements : Revolutionary Omega-3 Supplement Company Introduces Two Fresh Takes on Heart Health and Antioxidants
10. Irvine Pharmaceutical Services Introduces New Fill-and-Finish Subsidiary
11. Polar Introduces the RS800CX Training Management System for Multisport Endurance Athletes
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 2Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10How to reduce hospital stays and increase patient satisfaction 58689 1How to reduce hospital stays and increase patient satisfaction 58689 2Natural killer cells keep immune system in balance 10226 1Natural killer cells keep immune system in balance 10226 2Ardi displaces Lucy as oldest hominid skeleton 10222 1Ardi displaces Lucy as oldest hominid skeleton 10222 2Ardi displaces Lucy as oldest hominid skeleton 10222 3Ardi displaces Lucy as oldest hominid skeleton 10222 4Ardi displaces Lucy as oldest hominid skeleton 10222 5